The table below lists the 19 European dividend stocks most widely held in at least a third of the European dividend-focused mutual funds. In other words, the stocks listed in the table are held as a Top 30 holding by at least 6 of the 16 funds studied. In addition, the table also shows the subset of Morningstar 4- and 5-star rated funds that hold the same stocks.
Showing posts with label RHHBY. Show all posts
Showing posts with label RHHBY. Show all posts
Merger And Takeover Rumors In The Drug Industry - These Are The Best Dividend Yields To Catch!
Pharmacy stocks come into the focus of
investors. Novartis, a Swiss drug producer, announced a few big deals with
GlaxoSmithKline and Eli Lilly. Valeant Pharmaceuticals International wants to buy rival Allergan for USD 48 billion and Pfizer talked with AstraZeneca about a $100 billion takeover transaction.
The whole industry is still under pressure due
to the patent cliff but there are also big opportunities due to an aging
population. The risks are cost pressure by the government. Politicians want a
cheap care for the population. However, below is an overview of the largest
drug makers and their dividend payments. I've only published those stocks with
a market cap above USD 100 billion. What do you think - who has the best position to create big shareholder values?
The biggest pharma stocks are...
The biggest pharma stocks are...
Subscribe to:
Posts (Atom)